Regulatory Workshop

Industry's Commitment to Safe and Healthy Donors

Register to attend PPTA's workshop on June 10 (1:00 pm to 5:00 pm) in conjunction with this year's Plasma Protein Forum in Reston, Virginia.

The workshop will explore ongoing industry efforts to maintain the health and safety of individuals who donate Source Plasma. The workshop will describe the Source Plasma donor population, from donor demographics and donation frequency, to donor eligibility requirements and industry response to donor adverse events. Workshop attendees will go inside today's plasma centers to learn how industry compliance, mandatory government regulations and the International Quality Plasma Program (IQPP) helps to foster a healthy donor base and a safe donation experience. The Food and Drug Administration (FDA) will outline the history of its Source Plasma donor eligibility requirements and its current considerations surrounding changes to the requirements in a proposed rule published in 2007. FDA is also expected to present its analysis of donor adverse events. The workshop will culminate with a session on donor surveillance highlighting PPTA successes, current practices and future initiatives. The workshop will provide ample opportunity for attendee interaction during panel discussions. Attendees can engage with FDA representatives as well as PPTA staff and members, including the Chairs of the Source Board of Directors and the Regulatory Policy and Compliance Steering Committee and members of the Medical Policy Committee.

June 10, 2013
Hyatt Regency Reston
Seating is limited – Registration is required.
Please complete the registration form to register for this workshop
(there is no fee for the workshop).

Please contact Michelle Mason for additional information.

mmason@pptaglobal.org
Phone: (443) 433-1106
Fax: (410) 263-2298